Atlas Trials

Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance

Clinical trial NCT05602168 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05602168
Sponsor
Institut Paoli-Calmettes
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hematologic Cancer
Start date
2023-01-01
Primary completion
2030-01-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.